Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks Jimmy for the RXMD history review.
Yes it will, and remember their are only 608000 shares outstanding.
Awesome news!!!
Sustainable Green Team, Ltd. (SGTM) Reports Over $9.2 Million in Revenue for Q1 Ending April 3, 2021, After Recording Over $30.5 Million in Revenue for Fiscal Year 2020
ORLANDO, Fla., June 08, 2021 (GLOBE NEWSWIRE) -- Sustainable Green Team, Ltd. (OTC: SGTM) (“SGTM” or the “Company”), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, today announces another successful quarter after a strong 2020 YE.??
The Company recorded $9,291,931 in revenue with $1,400,720 in gross profit and $41,477,914 in total assets for the three months ending April 3, 2021. SGTM entered 2021 with approximately a 16.7% increase in revenue, an 8.6% increase in gross profit, and a 1.4% increase in total assets compared to the three months ended March 31, 2020.
SGTM’s CEO and Director Tony Raynor states, “Our continues successful recorded financials each quarter and year end is all thanks to our team. I’m a firm believer that you are only as strong as your team, and our strong growing financials proves such. This year we are anticipating to continue recording strong financials as we start implementing our strategy for 2021 we plan to share soon as they progress.”
About Sustainable Green Team, Ltd. (SGTM)
Sustainable Green Team, Ltd. (“SGTM”), through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The Company was established with the objective of providing a solution for the treatment and handling of tree debris that has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. The Company’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting tree debris through its tree services division and collection sites and then, through its processing division, recycling and using that tree debris as a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers. The Company plans to expand its operations through a combination of organic growth and strategic acquisitions that are both accretive to earnings and are positioned for rapid growth from the resulting synergistic opportunities identified. The Company’s customers include governmental, residential and commercial clients.
SGTM currently has two wholly owned subsidiaries to efficiently assess impacted areas, recover, manufacture, and distribute:
National Storm Recovery, LLC
National Storm Recovery, LLC (“NSR”), is composed of a team that has expertise in dangerous tree removal, debris hauling and debris management. The Company’s management team assesses storms by deploying its mobile command center to designated sites and then strategizing with its national partners, which include government agencies, prime contractors and subcontractors.
Central Florida Arborcare (“CFA”), a DBA of NSR has spent more than 40 years perfecting its technique for proper tree care, removal and services. From tree removal, stump grinding, tree care, grapple hauling and storm recovery, CFA ensures properties remain safe and businesses can continue as usual. ?To learn more please visit: https://www.centralfloridaarborcare.com
Mulch Manufacturing, Inc.
Mulch Manufacturing, Inc. (“MMI”), being vertically integrated, receives large volumes of wood fiber recovered from Central Florida Arborcare to feed raw material needs. MMI has the product line and distribution system to address a substantial customer base, which can be expanded.?To learn more please visit: https://mulchmfg.com
For additional information regarding SGTM’s operations, expansion plans and production facilities, view the Company’s presentation.
SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, listing on the CSE, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will" and other similar expressions, are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise. No information in this press release should be construed in any matter whatsoever as an indication of the future performance of the Company’s revenues, financial condition or stock price.
Company Contact:?Anthony Raynor?CEO & Director?407.886.8733 Office
Corporate Communications: ?InvestorBrandNetwork (IBN) ?Los Angeles, California ?www.InvestorBrandNetwork.com?310.299.1717 Office?Editor@InvestorBrandNetwork.com
?
Scott’s video last Friday explains most of your concerns.
In one of the Friday videos, Scott mentioned that they were targeting the end of the month to get current.
Click on Videos
The hype I’m referring to, is what Shital Mars leaked out last spring.
I believe the quiet period only pertains to the facts, not hype and speculation.
Yes I remember all of the speculation hype concerning Oleg Firer, and believe me Jay and Armen both read these postings so they need to come clean about what they are trying to accomplish with this company.
The MMs know there is a deadline and they are pedal to the metal with the manipulation.
This is why Jay needs to clear the air, there’s too much speculation and assumptions, going all the way back to the NETE connection. Was there a connection or not, why the rewrite of the S-1 from 20 pages to 120 pages. What was it for?
I hope Scott gives us some solid information on directory.com after market close today.
Now that the R/S has been canceled, Jay or Armen needs to PR the reasons why this has been canceled. Also first quarter report should have been reviewed and approved by now, so we need reasons why and who is holding this back. If the big financial deal and acquisition from last year is off the table also, then management owes us an explanation there as well.
Management needs to clear the air and tell the shareholders what they were trying to accomplish this past year.
Thanks Renee, hopefully this will get more investors.
IMO, since SGTM is being sued for nonpayment by the PR company they hired , nobody is issuing PRs since November of last year. So these posters here are the fill-ins.
Checked out the new website listings in my zip code and got an impressive list of dentists and HVAC technicians.
News out!!
Share Share
Tweet Tweet
Forward Forward
Progressive Care, Inc. to Present Today at the Emerging Growth Conference.
Read more
MIAMI, FL – May 26, 2021 – Progressive Care, Inc. (RXMD) (the “Company”), a personalized healthcare services and technology company is pleased to announce that it has been invited to present at the Emerging Growth Conference on May 26, 2021
The next Emerging Growth Conference is presenting on May 26, 2021. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s Chief Executive Officer, Alan Jay Weisberg, in real-time.
Mr. Weisberg will perform a presentation and may subsequently open the floor for questions. Please ask your questions during the event and Mr. Weisberg will do his best to get through as many of them as possible.
Progressive Care, Inc. will be presenting at 11:30AM Eastern time for 30 minutes.
Please register here to ensure you are able to attend the conference and receive any updates that are released.
https://goto.webcasts.com/starthere.jsp?ei=1465229&tp_key=acb55f1b36&sti=rxmd
If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and we will also release a link to that after the event.
About the Emerging Growth Conference
The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time-efficient manner.
The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.
All sessions will be conducted through video webcasts and will take place in the Eastern time zone.
For more information about Progressive Care, please visit the company’s website. Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCoRx
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/
?
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,”“upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Find Out More
Facebook
Twitter
Link
Website
Copyright © 2021 Progressive Care, All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
Progressive Care
901 North Miami Beach Blvd
Suite 1 and 2
North Miami Beach, FL 33162
Add us to your address book
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
Email Marketing Powered by Mailchimp
More news, expanding to Europe!!
KULA AG Selects Curtis Mathes Grow Lights for European Operations
RALEIGH, N.C., May 25, 2021 /PRNewswire/ -- Curtis Mathes Corporation (OTC: TLED) subsidiary, Curtis Mathes Grow Lights, Inc. (CMGL) will supply KULA AG with the award-winning, full-spectrum Harvester® LED grow light for all of their European cultivation facilities. KULA AG will begin producing highly efficacious CBG (cannabigerol) and CBD (cannabidiol) hemp flower that will be targeted for various segments of the European market, including Switzerland. Their state-of-the-art cultivation facility in Liechtenstein will feature novel genetics created by world-renowned geneticists Adam Jacques and Christian West.
"We wish to set the new standard of hemp cultivation in Europe by introducing exciting novel genetics to a relatively quality-devoid market," said Philippe Schürmann, CEO and Founding Partner of KULA AG.
"We are going to produce high-quality, organically-grown hemp flower, complying with the European narcotic regulation (<0.20% THC content), while still maintaining equal terpene profiles as their original, high-THC counterparts. In addition, we are committed to constantly strive for new innovations by conducting unique breeding projects and novel research using the Harvester grow light system" added Tim Rockenbrod, Founding Partner of KULA AG.
The Harvester® lighting system incorporates Curtis Mathes Grow Light's C3 approach – Color, Coverage and Current. "Color" refers to lighting spectrum that will develop nutritional content, especially for leafy green vegetables and herbs. "Coverage" relates to lighting distribution necessary for consistent illumination of a given crop area. "Current" refers to lighting power necessary for deep penetration and higher crop yields.
"It's rewarding to see our technology being implemented on an international scale," said Robert Manes, Chief Operations Officer & Director of Curtis Mathes, "The combination of our unique spectrum and targeted photon delivery will provide KULA AG the greatest opportunity to maximize the yield and phytochemical content of their hemp crops."
About Curtis Mathes Corporation (TLED): TLED is focused on research, development, manufacturing, and sales of state-of-the-art Solid-State Lighting (SSL) in various frequency-specific lighting technologies industries. www.curtismathes.com / www.cmgrowlights.com / YouTube® Channel
Forward Looking Statements: This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, and could cause actual outcomes and results to differ materially from the current expectations. No forward-looking statement can be guaranteed. Forward-looking statements in the press release should be evaluated together with the many uncertainties that affect Curtis Mathes Corporation's business and the Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.
View original content to download multimedia:http://www.prnewswire.com/news-releases/kula-ag-selects-curtis-mathes-grow-lights-for-european-operations-301298431.html
SOURCE Curtis Mathes Corporation
And more news!!
Curtis Mathes Collects Preliminary Data on Red Light Therapy Devices
FRISCO, Texas, May 18, 2021 /PRNewswire/ -- Curtis Mathes Corporation's (OTC: TLED) subsidiary, Curtis Mathes Therapeutics, Inc. (CMTI) has collected preliminary data from human subjects documenting the efficacy of their red light therapy (RLT) modules. CMTI's RLT units feature a novel spectrum of red light that has been shown in the scientific literature to greatly accelerate recovery from various injuries, including burns, lacerations and deep muscle tissue damage. In subjects with late-stage neurodegenerative diseases the daily use of CMTI's RLT modules lead to greater mobility and functionality of upper and lower extremities. These preliminary findings will serve as a basis for a large-scale clinical trial whereby the treatment of rheumatoid arthritis, chronic inflammation, and various degenerative neuropathies using RLT is characterized at the molecular level.
"These preliminary findings are incredibly encouraging," said Tina Crawford, Director of Operations at Curtis Mathes, "It is quite clear that our technologies may be able to give those struggling with various inflammation-related conditions, greater mobility and functionality with their extremities even after a short 90-120 second treatment."
"In my opinion, the results that I've witnessed using the Curtis Mathes device are nothing short of miraculous," said Rene Gamez, caregiver for a participant in ongoing trials , "This technology may provide those struggling with debilitating illnesses like ALS a tremendous opportunity for improved quality of life."
About Curtis Mathes Corporation (TLED): TLED is focused on research, development, manufacturing, and sales of state-of-the-art Solid-State Lighting (SSL) in various frequency-specific lighting technologies industries. www.curtismathes.com / www.cmgrowlights.com / YouTube® Channel
Forward Looking Statements: This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, and could cause actual outcomes and results to differ materially from the current expectations. No forward-looking statement can be guaranteed. Forward-looking statements in the press release should be evaluated together with the many uncertainties that affect Curtis Mathes Corporation's business and the Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.
View original content to download multimedia:http://www.prnewswire.com/news-releases/curtis-mathes-collects-preliminary-data-on-red-light-therapy-devices-301293433.html
SOURCE Curtis Mathes Corporation
News!!
Share Share
Tweet Tweet
Forward Forward
Progressive Care Announces Record Earnings and Revenue for Three Months Ended March 31, 2021
Read more
MIAMI, FL – May 18, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce the filing of the Company’s financial performance data setting new revenue and earnings records for the three months ended March 31, 2021.
“Our first quarter results exceeded expectations, driven by COVID-19 testing service demand and continued strong growth in third-party administrative services performed for 340B covered entities,” commented Alan Jay Weisberg, CEO and Chairman of Progressive Care, “Our ClearMetrX data analytics platform is nearing completion and we expect to see business come online from pharmacies and medical practices over coming quarters.”
Financial Highlights for Quarter Ended March 31, 2021
• Consolidated revenue for the quarter was $9.6 million, representing a year-over-year increase of 6% compared to Q1 2020
• Adjusted EBITDA of $141 thousand, an increase of over $780k over the adjusted EBITDA from Q1 2020
• Break even in cash flow from operating activities during Q1 2021
• Increased cash position to over $2.4 million from December 31, 2020
• Prescriptions filled during Q1 totaled approximately 116,000, representing a year-over-year decrease of 12% compared to Q1 2020
• 340B revenue contribution was approximately $724k, up 264% on a year-over-year basis when compared to Q1 2020
• Revenues associated with COVID testing totaled approximately $550k for the quarter
Cecile Munnik, CFO stated, “We project that our testing services will remain at or above our present levels and expect to benefit from ongoing testing and vaccinations as travel restrictions are lifted. The rapid test model has proven to be very profitable. To capitalize on this proven model, we are looking to expand our testing to other illnesses, including STDs, testing for various allergies, woman’s health and more. Some of the tests will require our pharmacies to get additional licensing. Our compliance team is working diligently on getting all the regulatory information so we can put into action our ultimate goal to have a hybrid model that offers both Lab and Pharmacy services under one roof.”
Operational Highlights for Quarter Ended March 31, 2021
• New Company record for Q1 performance in terms of both revenues and earnings
• Expanded COVID-19 Rapid Testing to 7 days a week thereby maximizing our hours of operations
• Completed relocations of PharmCo 901 and PharmCo 1103, providing expanded growth
potential and access to a wider base of customers and providers
• Expanded number of contracts for 340B pharmacy dispensing and TPA services
• Received approval to administer Covid-19 vaccines to customers
Management notes that the 12% year-over-year decline in filled prescriptions was attributable to downtime related to relocation of pharmacy operations for PharmCo 901 and PharmCo 1103, and the implementation of a new pharmacy software platform. PharmCo 901 was moved from its former location at North Miami Beach to its new expanded 11,000 Sq.ft location at Hallandale Beach, which necessitated a temporary closure of the North Miami Beach location prior to the opening of operations at Hallandale Beach. PharmCo 1103 was moved from a small location in Orlando to a much larger, 4,000 Sq.ft location.
Management believes these factors represent temporary obstacles and anticipate that volume will pick back up during the remainder of 2021. Furthermore, the new locations for both PharmCo 901 and 1103 are expansions that we expect will allow for organic growth in core pharmacy operations. In conclusion, Mr. Weisberg added, “We believe that Q1 2021 has been a promising start to accomplishing each of the Company’s goals. As we progress through the year, it will be important to keep our management team’s vision for Progressive Care in mind. The healthier we make our patients, the more successful our business will be, and we will not lose sight of that vision, with the added goal of enhancing and creating more value for our shareholders.”
For more information about Progressive Care, please visit the company’s website.
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCoRx
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,”“upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Find Out More
Facebook
Twitter
Link
Website
Copyright © 2021 Progressive Care, All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
Progressive Care
901 North Miami Beach Blvd
Suite 1 and 2
North Miami Beach, FL 33162
Add us to your address book
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
Email Marketing Powered by Mailchimp
Looking at number of shares Outstanding from 3/31/2021 to May 14, 2021 the dilution was less than 108,000 shares.
Just read it also, a lot of paper shuffling with the audited financials.
IMO, Mullens financials have not been finalized for their S-1 listing. This is why the are being penalized by NETE every day. So, you are probably right, the accountants are holding up the process.
We have more good news!!
Curtis Mathes Published Again in Cannabis Science and Technology Magazine
RALEIGH, N.C., May 11, 2021 /PRNewswire/ -- Curtis Mathes Corporation (OTC: TLED) has published another article in the peer-reviewed technical journal Cannabis Science and Technology, covering the environmental implications of energy consumption in cannabis cultivation. The article documents the differences in electrical consumption, electrical grid loading, CO2 emissions, and waste heat production between the Curtis Mathes Grow Lights (CMGL) Harvester® LED grow light and traditional High Pressure Sodium (HPS) lighting. The commentary piece also addresses the costs associated with electrical use and HVAC operations under the two different lighting technologies. The article was published in the current April issue (link below).
https://www.cannabissciencetech.com/view/the-environmental-implications-of-energy-consumption-in-cannabis-cultivation ;
"It's important to disseminate accurate information that can be used to make informed decisions about horticultural lighting and cultivation operations," said Robert Manes, President, Chief Operating Officer, & Director for Curtis Mathes, "Not only is our Harvester light producing highly efficacious plant material for our retail and commercial clients, but the paradigm shift toward LED technologies is helping to improve the environmental stewardship of cannabis cultivation."
"As we do with any analytical testing data that we receive from Harvester customers, it's important for us to internalize operational data to better characterize the impacts that our lights have on the environment," said Dr. Zacariah Hildenbrand, Chief Scientific Officer and Director of Curtis Mathes, "With the industry making a shift towards more sustainable cultivation practices, the greatest opportunity to improve one's carbon footprint is to implement energy-efficient, full-spectrum LEDs."
About Curtis Mathes Corporation (TLED): TLED is focused on research, development, manufacturing, and sales of state-of-the-art Solid-State Lighting (SSL) in various frequency-specific lighting technologies industries. www.curtismathes.com / www.cmgrowlights.com / YouTube® Channel
Forward Looking Statements: This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, and could cause actual outcomes and results to differ materially from the current expectations. No forward-looking statement can be guaranteed. Forward-looking statements in the press release should be evaluated together with the many uncertainties that affect Curtis Mathes Corporation's business and the Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.
View original content to download multimedia:http://www.prnewswire.com/news-releases/curtis-mathes-published-again-in-cannabis-science-and-technology-magazine-301288242.html
SOURCE Curtis Mathes Corporation
Thanks just adding it to my millions of RXMD. What a great company, been here since 2014.
This is from the March issue, IRS was very slow with processing my return.
Yes!! Just spent my stimulus check and added some more RXMD.
Trading shows it was a sell order.
News !!
Curtis Mathes Enters Relationship with Dynamic Research and Development
RALEIGH, N.C., May 5, 2021 /PRNewswire/ -- Curtis Mathes Corporation (OTC: TLED) has entered into a relationship with the privately-held genetics company Dynamic Research and Development (DRD) to be the lighting provider for all three of DRD's breeding facilities. This move brings the award-winning, full-spectrum Harvester® LED grow light to a highly-esteemed genetics company operating in the cannabis space; building on the success of the evolving partnership with hemp genetics company, ZED Therapeutics.
"Our team specializes in novel cannabis genetics that produce a wide range of cannabinoid, terpene, and flavonoid profiles," said Michael Martini, Managing Partner of DRD, "If we're going to continue to innovate we need to be surrounded by the best available technology, and that is what we've found in the Harvester® LED by Curtis Mathes Grow Lights."
The Harvester® lighting system incorporates CMGL's C3 approach – Color, Coverage and Current. "Color" refers to lighting spectrum that will develop nutritional content, especially for leafy green vegetables and herbs. "Coverage" relates to lighting distribution necessary for consistent illumination of a given crop area. "Current" refers to lighting power necessary for deep penetration and higher crop yields.
"Having industry leaders put their trust in our technology is incredibly rewarding and really speaks to the design and performance of the Harvester®," said Paul Williams, Chairman & Chief Executive Officer for Curtis Mathes, "The feedback from retail and commercial customers has been very favorable in terms of the yield and medicinal content that growers are achieving with our lighting system."
About Curtis Mathes Corporation (TLED): TLED is focused on research, development, manufacturing, and sales of state-of-the-art Solid-State Lighting (SSL) in various frequency-specific lighting technologies industries. www.curtismathes.com / www.cmgrowlights.com / YouTube® Channel
Forward Looking Statements: This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, and could cause actual outcomes and results to differ materially from the current expectations. No forward-looking statement can be guaranteed. Forward-looking statements in the press release should be evaluated together with the many uncertainties that affect Curtis Mathes Corporation's business and Curtis Mathes Corporation undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.
View original content to download multimedia:http://www.prnewswire.com/news-releases/curtis-mathes-enters-relationship-with-dynamic-research-and-development-301284097.html
SOURCE Curtis Mathes Corporation
We hit the nail on the head with the T-trade.
I wouldn’t be all that surprised to see another large T- trade after hours today. Something is strange about today’s trading activity. IMO
With the price of lumber skyrocketing from $400 per 1000 square feet to $1000- $1200 per square feet SGTM will benefit greatly this next quarter. They were paid to clear out storm and hurricane debris and now they have converted that debris into lumber and mulch. It will be reflected in this quarter and 2nd quarter earnings.
It could be if an insider is buying those shares and putting more skin into the company. That would be extremely bullish. IMO
And with the economy rebounding, the revenues from the spinoff could really accelerate the second half of 2021. IMO
It would certainly make RXMD more attractive to up listing if it became debt free. .50 -$1.00 would be quite possible and a reverse split of 10 to 1 or less would be quite reasonable.
No sure , just another theory. After all if NETE is merging the spin-off that money would eventually become RXMD’s.
Since there was a very small increase in dilution, is it possible the fines Mullens has been paying which amounts to approximately $1 million so far is being used to settle these T trades. That would cover that 10 million share T trade and possibly the others after that without diluting the O/S.
Actually Gallagher diluted almost 740 million more shares.
Based upon what I read, the information Gallagher gave us was very evasive. There was no new information that was any different from the 4/20 PR.